Arlex Chemi Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 23-06-2024
- Paid Up Capital ₹ 4.28 M
as on 23-06-2024
- Company Age 38 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 234.96 M
as on 23-06-2024
- Revenue 21.30%
(FY 2023)
- Profit 38.37%
(FY 2023)
- Ebitda 52.21%
(FY 2023)
- Net Worth 11.19%
(FY 2023)
- Total Assets 27.99%
(FY 2023)
About Arlex Chemi
The Corporate was formerly known as Sunrays Builders Private Limited. The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.28 M.
The company currently has active open charges totaling ₹23.50 Cr.
Bhavesh Shah, Laxman Chavan, Bhivaji Dhumal, and One other member serve as directors at the Company.
- CIN/LLPIN
U70200MH1985PTC037896
- Company No.
037896
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 1985
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai City, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Arlex Chemi Private Limited offer?
Arlex Chemi Private Limited offers a wide range of products and services, including Industrial Dyes, Vat Dyes, Textile Dyes, Dyes & Color Additives, Cosmetics, Hair & Beauty Products, Cosmetic Raw Material, Beauty Cosmetics, Water Dispensers, Voltas Water Dispensers.
Who are the key members and board of directors at Arlex Chemi?
Board Members(4)
Financial Performance and Corporate Structure Insights of Arlex Chemi.
Arlex Chemi Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.3% increase. The company also saw a substantial improvement in profitability, with a 38.37% increase in profit. The company's net worth Soared by an impressive increase of 11.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arlex Chemi?
In 2023, Arlex Chemi had a promoter holding of 89.37% and a public holding of 10.63%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Integrated Medicines Private Limited
Active
33 years 11 days Bhavesh Shah and Sanjay Dhadve are mutual person
Arlex Dyes And Intermediates Private Limited
Active 4 years 11 months Bhavesh Shah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Sep 2023 | ₹15.00 Cr | Open |
Yes Bank Limited Creation Date: 14 Sep 2023 | ₹7.00 Cr | Open |
Axis Bank Limited Creation Date: 19 Mar 2020 | ₹4.96 M | Open |
How Many Employees Work at Arlex Chemi?
Arlex Chemi has a workforce of 30 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jun 11, 2012, Arlex Chemi has raised a total of ₹ 1.5 M, with the most recent deal valued at ₹ 1 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
